nodes	percent_of_prediction	percent_of_DWPC	metapath
Equilin—HSD17B1—Metabolism of steroid hormones and vitamin D—GC—chronic obstructive pulmonary disease	0.154	0.482	CbGpPWpGaD
Equilin—Estropipate—CYP1A2—chronic obstructive pulmonary disease	0.134	0.198	CrCbGaD
Equilin—Estrone—CYP1A1—chronic obstructive pulmonary disease	0.0867	0.128	CrCbGaD
Equilin—Conjugated Estrogens—CYP1A2—chronic obstructive pulmonary disease	0.0838	0.123	CrCbGaD
Equilin—Estrone—CYP1A2—chronic obstructive pulmonary disease	0.0836	0.123	CrCbGaD
Equilin—Estropipate—ALB—chronic obstructive pulmonary disease	0.0775	0.114	CrCbGaD
Equilin—Estradiol—CYP1A1—chronic obstructive pulmonary disease	0.0657	0.0966	CrCbGaD
Equilin—Estradiol—CYP1A2—chronic obstructive pulmonary disease	0.0633	0.0932	CrCbGaD
Equilin—Estrone—ALB—chronic obstructive pulmonary disease	0.0483	0.071	CrCbGaD
Equilin—Estradiol—ALB—chronic obstructive pulmonary disease	0.0366	0.0538	CrCbGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.0158	0.0494	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—APIP—chronic obstructive pulmonary disease	0.0109	0.0341	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.01	0.0312	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.0078	0.0243	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00724	0.0226	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.00718	0.0224	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GC—chronic obstructive pulmonary disease	0.00705	0.022	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00655	0.0204	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.00606	0.0189	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.00522	0.0163	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.00459	0.0143	CbGpPWpGaD
Equilin—HSD17B1—Disease—HDAC2—chronic obstructive pulmonary disease	0.00386	0.0121	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.00385	0.012	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.0038	0.0119	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.0037	0.0115	CbGpPWpGaD
Equilin—HSD17B1—Disease—KL—chronic obstructive pulmonary disease	0.00359	0.0112	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.00355	0.0111	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.00347	0.0108	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0032	0.00998	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.0027	0.00844	CbGpPWpGaD
Equilin—HSD17B1—Disease—ERBB3—chronic obstructive pulmonary disease	0.00269	0.0084	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.00267	0.00833	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.00263	0.00821	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.00251	0.00785	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.00245	0.00765	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00232	0.00725	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.00232	0.00724	CbGpPWpGaD
Equilin—HSD17B1—Disease—NOS2—chronic obstructive pulmonary disease	0.00224	0.007	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.00207	0.00647	CbGpPWpGaD
Equilin—HSD17B1—Disease—SERPINE1—chronic obstructive pulmonary disease	0.00189	0.0059	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.00188	0.00588	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.00181	0.00566	CbGpPWpGaD
Equilin—HSD17B1—Disease—NOS3—chronic obstructive pulmonary disease	0.0018	0.00563	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.00169	0.00526	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ALB—chronic obstructive pulmonary disease	0.00158	0.00493	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NOS3—chronic obstructive pulmonary disease	0.00151	0.00472	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.00132	0.00413	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.00126	0.00394	CbGpPWpGaD
Equilin—HSD17B1—Disease—TGFB1—chronic obstructive pulmonary disease	0.00119	0.00372	CbGpPWpGaD
Equilin—HSD17B1—Disease—EGFR—chronic obstructive pulmonary disease	0.00117	0.00365	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.00112	0.0035	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.00101	0.00316	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.00091	0.00284	CbGpPWpGaD
Equilin—HSD17B1—Disease—IL6—chronic obstructive pulmonary disease	0.000899	0.00281	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.000836	0.00261	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	0.000819	0.00256	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	0.000688	0.00215	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	0.00063	0.00196	CbGpPWpGaD
